Markel Group Inc. Buys 1,750 Shares of HCA Healthcare, Inc. $HCA

Markel Group Inc. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.2% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 82,430 shares of the company’s stock after acquiring an additional 1,750 shares during the period. Markel Group Inc.’s holdings in HCA Healthcare were worth $39,009,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Simplicity Wealth LLC boosted its stake in shares of HCA Healthcare by 81.4% in the 1st quarter. Simplicity Wealth LLC now owns 880 shares of the company’s stock valued at $417,000 after purchasing an additional 395 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in HCA Healthcare by 12.9% in the first quarter. Sequoia Financial Advisors LLC now owns 6,100 shares of the company’s stock valued at $2,887,000 after buying an additional 698 shares in the last quarter. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth approximately $33,000. Equitable Trust Co. boosted its holdings in shares of HCA Healthcare by 1.3% in the 1st quarter. Equitable Trust Co. now owns 160,475 shares of the company’s stock worth $75,943,000 after acquiring an additional 2,036 shares in the last quarter. Finally, Kestra Advisory Services LLC increased its holdings in HCA Healthcare by 3.2% during the 1st quarter. Kestra Advisory Services LLC now owns 5,238 shares of the company’s stock valued at $2,479,000 after purchasing an additional 160 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA Healthcare stock traded down $2.56 during trading hours on Friday, reaching $406.45. 1,651,230 shares of the company’s stock traded hands, compared to its average volume of 1,367,535. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm’s 50 day moving average is $397.56 and its 200-day moving average is $460.39. The firm has a market capitalization of $90.17 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the firm earned $6.45 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Analyst Ratings Changes

Several analysts have recently commented on HCA shares. Wells Fargo & Company decreased their target price on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Argus dropped their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. KeyCorp decreased their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Finally, Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $497.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.